Top in hem/onc: Breast cancer overdiagnosed, high-risk prostate cancer tool

Data from a study found that one in seven women in the U.S. will be overdiagnosed with breast cancer in their lifetimes.

The data, which also found that over one third of these cases are linked to non-progressive cancers, was presented at the San Antonio Breast Cancer Symposium and was the top story in hematology/oncology last week.

Another top story covered the PSMA PET/CT-specific nomogram, a proxy that was highly effective in predicting high-risk prostate cancer outcomes and improving risk-stratification.

Read these and more top stories in hematology/oncology below:

Breast cancer overdiagnoses in U.S. common, inaccurately reported

One in seven U.S. women will be overdiagnosed with breast cancer during their lifetimes, according to study results presented at San Antonio Breast Cancer Symposium. Read more.

New tool may improve risk stratification of men with high-risk prostate cancer

A proxy for prostate-specific membrane antigen PET/CT upstaging was strongly predictive of meaningful, long-term cancer-specific outcomes, according to results of a multinational cohort study published in JAMA Network Open. Read more.

Women less likely to ask for deadline extensions than men, study shows

Women are more likely to feel uncomfortable than men to ask for more time on adjustable deadlines at work or school, leading to higher rates of time stress and burnout, according to study results. Read more.

Cultivating the calm with the chaos: Self-care should be priority for APPs

Exhaustion. Fear. Burnout. Uncertainty. Stress. Trauma. Grief. How do these words resonate with you? Read more.

COVID-19 vaccination may be less effective for patients with multiple myeloma

Although vaccination is an effective strategy for COVID-19 prevention, its effectiveness may be reduced in patients with multiple myeloma, likely because of immunosuppression due to the disease process and related therapy. Read more.